Target intelligence / Profile preview

NADH-ubiquinone oxidoreductase chain 1 (ND1)

Target
ND1
Molecular classification
Enzyme, Mitochondrial respiratory chain complex subunit
01

Overview

NADH-ubiquinone oxidoreductase chain 1 (ND1) is a core, mitochondrially encoded subunit of Complex I (NADH:ubiquinone oxidoreductase), the largest enzyme complex in the mitochondrial electron transport chain[5][7][8]. ND1 is essential for the catalytic function of Complex I, which transfers electrons from NADH to ubiquinone (coenzyme Q10), coupling this process to the active translocation of protons across the mitochondrial inner membrane[1][2][3]. This generates an electrochemical gradient used for ATP synthesis by ATP synthase. ND1 forms part of the membrane arm that anchors Complex I in the inner membrane and participates directly in proton translocation and electron transfer. Defects or mutations in ND1 are linked to mitochondrial diseases and impaired energy metabolism, contributing to disorders such as Leber hereditary optic neuropathy and other neuromuscular syndromes[4]. Complex I is also a pharmacological target for several natural and synthetic inhibitors, including rotenone and piericidin, which disrupt energy metabolism and are used experimentally to study mitochondrial dysfunction and its consequences[1][4].

Other names
ND1NADH dehydrogenase subunit 1Complex I chain 1
02

Mechanism of action

Inhibition of electron transfer from NADH to ubiquinone, disrupting ATP production and increasing oxidative stress

03

Biological functions

Electron transportOxidative phosphorylationProton transport/pumpingATP productionCellular respiration
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseMitochondrial disorders (e.g., Leber hereditary optic neuropathy, MELAS syndrome)Other
05

Safety considerations

Inhibiting or disrupting ND1/Complex I can cause cellular energy deficits, lactic acidosis, neurotoxicity, and heightened susceptibility to oxidative stress and cell death (apoptosis), particularly in metabolically active tissues (e.g., brain, heart)
06

Interacting drugs

Rotenone

2 more in the full profile.

07

Biomarkers

ND1 mutations or levels used as mitochondrial dysfunction biomarkers in inherited mitochondrial diseasesMeasurement of Complex I activity in muscle biopsies or fibroblast samples for diagnosis

Beyond the preview

Go deeper on NADH-ubiquinone oxidoreductase chain 1 (ND1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH-ubiquinone oxidoreductase chain 1 (ND1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call